New covid-19 vaccine Covaxin has improved hopes of Indians after the successful trials on monkey. It is now all set to start phase-1 human trials approved by ICMR. For the Human trials of India’s indigenous Covid19 vaccine COVAXIN, 12 hospitals are selected. They will enrol participants this month, samples of Bharat Biotech’s COVAXIN are still undergoing quality and safety tests at a govt lab. Theses tests started last Friday and are expected to be finished by the end of next week. Three of the selected hospitals – Delhi’s AIIMS, Kancheepuram’s SRM Hospital and Research Centre and Vishakhapatnam’s King George Hospital are still awaiting ethics committee approvals to begin enrollment of participants for the study.
Besides Sinovac, the vaccines developed by AstraZeneca-university of Oxford and Sinopharm are the only other candidates to start third stage trial.
US-based Moderna is planning to start its late-stage trial for potential vaccine candidates in July.
Coronavirus COVID-19 vaccine India
India is making significant progress in producing the probable Coronavirus COVID19 vaccine. Many institutions in India are engaged in Research and Development for Corona vaccines in the country. Accordin to information provided by Pune based ICMR institution, National Institute of Virology and Hyderabad based CSIR institution Center for Cellular and Molecular Biology, six Indian companies are working on probable vaccine candidate for Coronavirus.
COVID19 vaccine can be developed by 2021, says WHO scientist! The chief scientist at the World Health Organization (WHO) Soumya Swaminathan has said that at least one COVID19 vaccine will be ready by 2021. Swaminathan said that we can be hopeful of seeing one “safe and efficacious” COVID-19 vaccine by the next year. Swaminathan has revealed that WHO has been discussing methods for “fair distribution of the vaccine” with its member countries.